Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan
References (29)
- et al.
Sumatriptan and chest pain
Lancet
(1993) - et al.
The relation of patient satisfaction with treatment of otitis externa to clinical outcomes: Development of an instrument
Clin Ther.
(1999) - et al.
A multinational investigation of the impact of subcutaneous sumatriptan. I: Design, methods and clinical findings
Pharmacoeconomics
(1997) - et al.
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors
JAMA
(1992) - et al.
Risk factors for headache recurrence after sumatriptan: A study in 366 migraine patients
Cephalalgia
(1996) - et al.
Improvement in migraine-specific quality of life in a clinical trial of rizatriptan
Cephalalgia
(1997) - et al.
A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life
Pharmacoeconomics
(1997) - et al.
A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activity
Pharmacoeconomics
(1997) - et al.
A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction
Pharmacoeconomics
(1997) - et al.
A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache
Can J Neurol Sci.
(1992)
Which properties do patients expect of new and improved drugs in the treatment of primary headache disorders?
More than a headache
Harv Health Lett.
(1998)
Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan
Headache
(1998)
(1998)
Cited by (0)
Copyright © 2001 Published by Elsevier Inc.